Marshall Financial Group, LLC HALO Holdings History
Marshall Financial Group, LLC's Halozyme Therapeutics Inc Holding Summary
As of 2025-06-30, Marshall Financial Group, LLC held - shares of Halozyme Therapeutics Inc(HALO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Marshall Financial Group, LLC now holds 0% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2024Q4. And since then Marshall Financial Group, LLC has made 2 purchases of HALO, at an average price of $51.51, for a total of 33,545.00 shares. In addition, there have been 1 sales at an average price of $57.01 for 33,545.00 shares. Based on historical transaction data and HALO's current price of $58.47, Marshall Financial Group, LLC's estimated gain on his HALO holdings is $184,550.70, reflecting a 10.68% gain to date.
Marshall Financial Group, LLC HALO ($58.47) Holding Chart
Marshall Financial Group, LLC HALO ($58.47) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
